[go: up one dir, main page]

IL95169A0 - Semisynthetic ganglioside analogues - Google Patents

Semisynthetic ganglioside analogues

Info

Publication number
IL95169A0
IL95169A0 IL95169A IL9516990A IL95169A0 IL 95169 A0 IL95169 A0 IL 95169A0 IL 95169 A IL95169 A IL 95169A IL 9516990 A IL9516990 A IL 9516990A IL 95169 A0 IL95169 A0 IL 95169A0
Authority
IL
Israel
Prior art keywords
acyl
dilysogangliosides
derived
carbon atoms
unsubstituted aliphatic
Prior art date
Application number
IL95169A
Other languages
English (en)
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of IL95169A0 publication Critical patent/IL95169A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lead Frames For Integrated Circuits (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
IL95169A 1989-07-27 1990-07-24 Semisynthetic ganglioside analogues IL95169A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8948246A IT1232175B (it) 1989-07-27 1989-07-27 Analoghi semisintetici di gangliosidi

Publications (1)

Publication Number Publication Date
IL95169A0 true IL95169A0 (en) 1991-06-10

Family

ID=11265466

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95169A IL95169A0 (en) 1989-07-27 1990-07-24 Semisynthetic ganglioside analogues

Country Status (16)

Country Link
US (1) US5484775A (no)
EP (1) EP0410881B1 (no)
JP (1) JPH0358995A (no)
KR (1) KR910002887A (no)
AT (1) ATE158297T1 (no)
AU (1) AU5982990A (no)
CA (1) CA2022138A1 (no)
DE (1) DE69031448T2 (no)
ES (1) ES2106025T3 (no)
FI (1) FI903753A0 (no)
HU (1) HU210923B (no)
IL (1) IL95169A0 (no)
IT (1) IT1232175B (no)
NO (1) NO903333L (no)
NZ (1) NZ234649A (no)
PL (1) PL165209B1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1239060B (it) * 1990-05-04 1993-09-20 Fidia Spa Processo per la modulazione selettiva dell'espressione e della funzione di un determinante sulla superficie cellulare attraverso appropriati agenti chimici
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
MXPA04001831A (es) 2001-08-29 2004-07-08 Neose Technologies Inc Nuevos derivados sinteticos de gangliosidos y composiciones de los mismos.
JP2006519878A (ja) 2003-03-06 2006-08-31 ネオーズ テクノロジーズ， インコーポレイテッド ガングリオシドの酵素合成のための方法および化合物
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
WO2017062632A1 (en) 2015-10-09 2017-04-13 Tensar Corporation, Llc Geogrid made from a coextruded multilayered polymer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
JPH06795B2 (ja) * 1985-04-02 1994-01-05 理化学研究所 アシアロガングリオシド関連化合物の製造方法
CA1329591C (en) * 1987-06-26 1994-05-17 Richard R. Schmidt Pharmaceutical products and new lactosyl compounds and the preparation thereof
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
CA1339488C (en) * 1988-02-12 1997-10-07 Taeko Dohi De-n-acetyl-syalic acid and their applications as modifiers of cell physiology
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi

Also Published As

Publication number Publication date
HU210923B (en) 1995-09-28
ATE158297T1 (de) 1997-10-15
PL286249A1 (en) 1991-08-26
EP0410881A3 (en) 1993-01-20
EP0410881B1 (en) 1997-09-17
IT8948246A0 (it) 1989-07-27
NZ234649A (en) 1992-01-29
US5484775A (en) 1996-01-16
KR910002887A (ko) 1991-02-26
EP0410881A2 (en) 1991-01-30
DE69031448T2 (de) 1998-02-26
IT1232175B (it) 1992-01-25
FI903753A0 (fi) 1990-07-27
CA2022138A1 (en) 1991-01-28
ES2106025T3 (es) 1997-11-01
HUT54173A (en) 1991-01-28
HU904640D0 (en) 1991-01-28
PL165209B1 (pl) 1994-11-30
NO903333D0 (no) 1990-07-26
DE69031448D1 (de) 1997-10-23
JPH0358995A (ja) 1991-03-14
AU5982990A (en) 1991-01-31
NO903333L (no) 1991-01-28

Similar Documents

Publication Publication Date Title
ZA89861B (en) Indolocarbazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
NZ231590A (en) N-acyllysosphingolipids and pharmaceutical compositions thereof
IL95169A0 (en) Semisynthetic ganglioside analogues
EP0973518A4 (en) SEMISYNTHETIC METHOD FOR PRODUCING DIDEMNINE ANALOGS
PT85155A (en) Process for preparing pharmaceutical compositions for parenteral administration containing proteins having fibrinolytic activity
EP0410883A3 (en) Di-lysogangliosides derivatives
HUT53116A (en) Process for producing lysoganglioside derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
GB2230953B (en) Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease
Trimble Studies on cyclosporine analogs, asymmetric synthesis of α-hydrazinocarboxylic acids and biosynthetic studies using stable isotope NMR techniques
IT215627Z2 (it) Elemento di raccordo per frontali di mobili.
IT1225035B (it) Supporto incassabile perfezionato per il fissagio di ripiani di mobili
DZ1230A1 (fr) Procédé de préparation des cis-n-(3-méthoxy-4-pipéridinyl benzamides.